Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease

被引:213
作者
Liu, Jian [1 ]
Sempos, Christopher T.
Donahue, Richard P.
Dorn, Joan
Trevisan, Maurizio
Grundy, Scott M.
机构
[1] Brock Univ, St Catharines, ON L2S 3A1, Canada
[2] NIH, Bethesda, MD 20892 USA
[3] Univ Buffalo, Buffalo, NY USA
[4] Univ Texas, SW Med Ctr, Dallas, TX USA
关键词
D O I
10.1016/j.amjcard.2006.06.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine if non-high-density lipoprotein (HDL) cholesterol is a more useful predictor of coronary heart disease (CHD) risk than low-density lipoprotein (LDL) cholesterol and if very-low-density lipoprotein (VLDL) cholesterol is an independent predictor of CHD risk, data from the Framingham Heart Study (2,693 men, 3,101 women) were used for this analysis. All subjects were aged >= 30 years and free of CHD at baseline, and incident CHD was the end point (618 men, 372 women). Cox proportional-hazards models were used to assess the risk for CHD (relative risks and 95% confidence intervals) on the basis of the joint distribution of LDL cholesterol and non-HDL cholesterol (in milligrams per deciliter), as well as LDL cholesterol, non-HDL cholesterol, and VLDL cholesterol as continuous variables. After multivariate adjustment, within non-HDL cholesterol level, no association was found between LDL cholesterol and the risk for CHD, whereas within LDL cholesterol levels, a strong positive and graded association between non-HDL cholesterol and risk for CHD was observed. When the analysis was repeated within triglyceride levels (< 200 vs 2:200 mg/dl), the risk pattern did not change significantly. Also, VLDL cholesterol was found to be a significant predictor of CHD risk after adjusting for LDL cholesterol at triglyceride levels of < 200 or < 200 mg/dI. In conclusion, these results suggest that nonHDL cholesterol level is a stronger predictor of CHD risk than LDL cholesterol; that is, VLDL cholesterol may play a critical role in the development of CHD. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1363 / 1368
页数:6
相关论文
共 26 条
[11]   Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy [J].
Grundy, SM .
CIRCULATION, 2002, 106 (20) :2526-2529
[12]   Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target [J].
Grundy, SM .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) :1379-1380
[13]   Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes [J].
Jiang, R ;
Schulze, MB ;
Li, TC ;
Rifal, N ;
Stampfer, MJ ;
Rimm, EB ;
Hu, FB .
DIABETES CARE, 2004, 27 (08) :1991-1997
[14]  
Kahn HA., 1989, STAT METHODS EPIDEMI
[15]   INVESTIGATION OF CORONARY HEART-DISEASE IN FAMILIES - FRAMINGHAM OFFSPRING STUDY [J].
KANNEL, WB ;
FEINLEIB, M ;
MCNAMARA, PM ;
GARRISON, RJ ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (03) :281-290
[16]  
KESSLER G, 1965, TECHNICON S AUTOMATI, P341
[17]   HDL SERUM-CHOLESTEROL AND 24-YEAR MORTALITY OF MEN IN FINLAND [J].
KEYS, A ;
KARVONEN, MJ ;
PUNSAR, S ;
MENOTTI, A ;
FIDANZA, F ;
FARCHI, G .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1984, 13 (04) :428-435
[18]   Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease [J].
Kugiyama, K ;
Doi, H ;
Takazoe, K ;
Kawano, H ;
Soejima, H ;
Mizuno, Y ;
Tsunoda, R ;
Sakamoto, T ;
Nakano, T ;
Nakajima, K ;
Ogawa, H ;
Sugiyama, S ;
Yoshimura, M ;
Yasue, H .
CIRCULATION, 1999, 99 (22) :2858-2860
[19]   LIPIDS AND LIPOPROTEINS PREDICTING CORONARY HEART-DISEASE MORTALITY AND MORBIDITY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES [J].
LAAKSO, M ;
LEHTO, S ;
PENTTILA, I ;
PYORALA, K .
CIRCULATION, 1993, 88 (04) :1421-1430
[20]   Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes [J].
Liu, J ;
Sempos, C ;
Donahue, RP ;
Dorn, J ;
Trevisan, M ;
Grundy, SM .
DIABETES CARE, 2005, 28 (08) :1916-1921